Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Imaging

BOLD assessment—effects of RAAS inhibition in CKD

Blood-oxygen-level-dependent MRI enables noninvasive assessment of renal deoxyhaemoglobin levels and, therefore, hypoxia. As decreased tissue oxygenation might contribute to acute and chronic kidney disease (CKD), this tool has been examined in patients with CKD. Indeed, the benefits of renin–angiotensin–aldosterone system inhibitors might be partly conferred by increased oxygenation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Gloviczki, M. L. et al. Blood oxygen level-dependent magnetic resonance imaging identifies cortical hypoxia in severe renovascular disease. Hypertension 58, 1066–1072 (2011).

    Article  CAS  Google Scholar 

  2. Siddiqi, L. et al. Inhibition of the renin–angiotensin system affects kidney tissue oxygenation evaluated by magnetic resonance imaging in patients with chronic kidney disease. J. Clin. Hypertens. 16, 214–218 (2014).

    Article  CAS  Google Scholar 

  3. Manotham, K. et al. Angiotensin II receptor blocker partially ameliorated intrarenal hypoxia in chronic kidney disease patients: a pre-/post-study. Intern. Med. J. 42, e33–e37 (2012).

    Article  CAS  Google Scholar 

  4. Welch, W. J., Mendonca, M., Aslam, S. & Wilcox, C. S. Roles of oxidative stress and AT1 receptors in renal hemodynamics and oxygenation in the postclipped 2K,1C kidney. Hypertension 41, 692–696 (2003).

    Article  CAS  Google Scholar 

  5. Palm, F., Onozato, M., Welch, W. J. & Wilcox, C. S. Blood pressure, blood flow, and oxygenation in the clipped kidney of chronic 2-kidney, 1-clip rats: effects of tempol and angiotensin blockade. Hypertension 55, 298–304 (2010).

    Article  CAS  Google Scholar 

  6. Inoue, T. et al. Noninvasive evaluation of kidney hypoxia and fibrosis using magnetic resonance imaging. J. Am. Soc. Nephrol. 22, 1429–1434 (2011).

    Article  Google Scholar 

  7. Gloviczki, M. L. et al. Comparison of 1.5 and 3 T BOLD MR to study oxygenation of kidney cortex and medulla in human renovascular disease. Invest. Radiol. 44, 566–571 (2009).

    Article  CAS  Google Scholar 

  8. Michaely, H. J. et al. Renal BOLD–MRI does not reflect renal function in chronic kidney disease. Kidney Int. 81, 684–689 (2012).

    Article  CAS  Google Scholar 

  9. Pruijm, M. et al. Blockade of the renin-angiotensin system and renal tissue oxygenation as measured with BOLD–MRI in patients with type 2 diabetes. Diabetes Res. Clin. Pract. 99, 136–144 (2013).

    Article  CAS  Google Scholar 

  10. Textor, S. C. et al. The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis. J. Am. Soc. Nephrol. 19, 780–788 (2008).

    Article  Google Scholar 

Download references

Acknowledgements

The author is partly supported by NIH grants DK73608, DK100081, HL77131 and HL121561.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lilach O. Lerman.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lerman, L. BOLD assessment—effects of RAAS inhibition in CKD. Nat Rev Nephrol 10, 247–248 (2014). https://doi.org/10.1038/nrneph.2014.58

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2014.58

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing